CD163-, CD204-, and CD206-positive macrophages are significantly associated with poor prognosis, pTNM staging and lymph node metastasis in lung cancer8–10, and thus CD163, CD204, and CD206 are considered as useful markers for activation of TAMs. This evidence concerns the gene CD163 and metastatic malignant neoplasm in the lymph nodes.